THE IMPACT OF CIGARETTE SMOKING ON PLATELET RESPONSE TO CLOPIDOGREL IN CHINESE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

被引：0
|
作者：
Liu, Xin [1 ]
Xu, Ke [2 ]
Yuan, Yuan [3 ]
Wang, Xingyu [3 ]
机构：
[1] Beijing Hypertens League Inst, Human Genet Lab, Beijing, Peoples R China
[2] Harbin Med Univ, Dept Epidemiol, Harbin, Heilongjiang, Peoples R China
[3] Beijing Hypertens League Inst, Human Genet Lab, Beijing, Peoples R China
来源：
JOURNAL OF HYPERTENSION | 2018年 / 36卷
关键词：
ADP-induced platelet inhibition rare; clopidogrel; smoking; HTPI;
D O I：
10.1097/01.hjh.0000548889.94074.5e
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
A14513
引用
收藏
页码：E217 / E218
页数：2
相关论文
共 50 条
  • [31] PXR polymorphisms have impact on the clinical efficacy of clopidogrel in patients undergoing percutaneous coronary intervention
    Wu, Yan
    Yu, Hua
    Tang, Hai-qin
    Su, Yong
    Shi, Tian-lu
    Liu, Sheng
    Xia, Quan
    Xu, Du-juan
    [J]. GENE, 2018, 653 : 22 - 28
  • [32] Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions
    Beitelshees, A. L.
    Horenstein, R. B.
    Vesely, M. R.
    Mehra, M. R.
    Shuldiner, A. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 455 - 459
  • [33] EVALUATION OF RESPONSE TO LOADING DOSES OF CLOPIDOGREL THERAPY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)
    Saade, K.
    El-hamamsy, M.
    Hamdy, M.
    Magdy, A.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A114 - A115
  • [34] Correction to: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention
    Nejat Mahdieh
    Ahmad Rabbani
    Ata Firouzi
    Ali Zahedmehr
    Maryam Hoseinimoghaddam
    Sedigheh Saedi
    Hamidreza Sanati
    Hosseinali Basiri
    Feridoun Noohi
    Bahareh Rabbani
    Majid Maleki
    [J]. Cardiovascular Toxicology, 2018, 18 : 492 - 492
  • [35] The potential interaction of statins and clopidogrel in patients undergoing percutaneous coronary intervention
    Ibrahim, Tahani H.
    Alanazy, Hind S.
    Alharbi, Maram M.
    Ahmed, Safa M.
    [J]. INTERNATIONAL JOURNAL OF ADVANCED AND APPLIED SCIENCES, 2021, 8 (03): : 112 - 119
  • [36] Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
    Yang, Bin
    Zheng, Chunyan
    Yu, Haichu
    Zhang, Rui
    Li, Shan
    Tan, Lijuan
    Leng, Min
    Cai, Shanglang
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2018, 47 (07) : 952 - 957
  • [37] CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Zeb, Shah
    Shah, Ibrahim
    Adil, Mohammad
    Ali, Jabar
    Jan, Hikmatullah
    Gul, Adnan Mahmood
    Hafizullah, Mohammad
    [J]. PAKISTAN HEART JOURNAL, 2016, 49 (03): : 107 - 112
  • [38] Gene variants in responsiveness to clopidogrel have no impact on clinical outcomes in Chinese patients undergoing percutaneous coronary intervention - A multicenter study
    Li, Chenze
    Zhang, Lina
    Wang, Haoran
    Li, Sha
    Zhang, Yan
    You, Ling
    Sun, Yang
    Wang, Dong
    Yang, Jun
    Cui, Yinghua
    Cao, Yanyan
    Shen, Xiaoqing
    Wang, Yan
    Cui, Wei
    Yan, Jiangtao
    Zeng, Hesong
    Guo, Xiaomei
    Li, Jianjun
    Wang, Dao Wen
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 : 360 - 366
  • [39] Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
    Kwan, Joanne
    Htun, Wah Wah
    Huang, Yili
    Ko, Wilson
    Kwan, Tak W.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2011, 7 : 399 - 404
  • [40] Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Wang, He-Yang
    Li, Yi
    Xu, Xiao-Ming
    Li, Jing
    Han, Ya-Ling
    [J]. CHINESE MEDICAL JOURNAL, 2018, 131 (17) : 2017 - +
12345